IgA Nephropathy Treatment Market – Immunosuppressive Therapy Remains the Largest Segment
Immunosuppressive therapy remains the largest treatment segment in the IgA nephropathy treatment market, accounting for roughly 52.4% of market share. Its leadership reflects the role of immune-related mechanisms in the disease and the need for therapeutic approaches that address inflammation and potential kidney damage.marketresearchfuture Treatment selection depends on disease severity,...
0 Комментарии 0 Поделились 194 Просмотры 0 предпросмотр